Copyright: ©Author(s) 2026.
World J Gastroenterol. Nov 14, 2026; 32(42): 123972
Published online Nov 14, 2026. doi: 10.3748/wjg.123972
Published online Nov 14, 2026. doi: 10.3748/wjg.123972
Figure 1 Schematic summary of salidroside: Anti-ulcerative colitis mechanisms, translational barriers, and pharmacokinetic-based colon-targeted delivery strategies.
UC: Ulcerative colitis; GFAP: Glial fibrillary acidic protein; S100B: S100 calciumbinding protein B; IL-1β: Interleukin-1β; TNF-α: Tumor necrosis factor α; IL-6: Interleukin-6.
- Citation: Zhou YF, Yan JW, Tang FS. Letter to the Editor: Salidroside in ulcerative colitis - neuroimmune regulatory mechanisms and clinical translation prospects. World J Gastroenterol 2026; 32(42): 123972
- URL: https://www.wjgnet.com/1007-9327/full/v32/i42/123972.htm
- DOI: https://dx.doi.org/10.3748/wjg.123972